Cass empowers healthcare providers and those suffering from eating disorders to achieve a 46% reduction in prevalence over 6 months.

Cass provide behavioral coaching and support to reduce the costs and human toll of this disease.
A research study found a 46% reduction in eating disorder prevalence after 6 months.
Unlike traditional approaches, Cass does this through interactive text messaging and a AI knowledge engine, connected, when needed in times of crisis, to a network of therapists.
"A chatbot could help prevent eating disorders, new study finds"
Read the article
IBH LogoCascade LogoNemours Logo

Cass helps those challenged by eating disorders with AI-based chat technology.

24/7/365 access to care

Cass provides a low-cost, personalized, and scalable text solution available 24/7 to increase equitable access to eating disorder behavioral health support.

Connect to a network of crisis counselors

Use Cass's digital coach and triage process to solve problems immediately, and, when needed further scale support by tapping into Cass' 5,000 certified counselors network available on-demand in all 50 states.

Increasing adherence to medication and treatment plans

With automatic check-ins and timely reminders, ensure compliance to medication and different treatment plans.

Reduce the number of no-shows or readmission

Engage with users who have the potential for ED challenges, and later increase patient engagement via notification of resources and programs at the right moments.

Drive down the cost of engaging with ED patients

Differentiate your practice by promoting mental health care at scale via low-cost digital campaigns using a phone number. Engage more efficiently using text messaging.

Track your impact and adjust accordingly

Track impact, tailor customer care, and better align resources by reviewing customer data collected via health assessment intakes and engagement metrics.

Demonstrated real change and improvement for those prone to eating disorders

Ellen Fitzsimmons-Craft, assistant professor of psychiatry at Washington University School of Medicine in St. Louis said:  “[Cass] could have a great public health impact if we can continue to find ways to disseminate it widely.”